FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19709211000001109: Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Dec 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
66656301000001110 Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78133201000001119 Cabergoline 2mg tablets (DE Pharmaceuticals) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Is a Product containing precisely cabergoline 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) 20 tablet Has AMP True Cabergoline 2mg tablets (Doncaster Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start